bioMérieux launches rapid ENDOZYME® II GO


Developed by the R&D team of Hyglos - a bioMérieux company> more

New study by Eli Lilly supports full regulatory approval of rFC methods


PDA Journal of Pharmaceutical Science and Technology> more

Guidelines for Hold Time Study of Endotoxin [Low Endotoxin Recovery]


New article in EPR by Kevin Williams, Hyglos - a bioMérieux company> more

Product Focus in BioPharma Asia: Hyglos Addresses the Underlying Causes of Low Endotoxin Recovery (LER)


Demasking with Endo-RS® Ensures Full Recovery of Endotoxin Contaminants prior to LAL Detection> more

GMP Workshop on Low Endotoxin Recovery 13/14 December 2016


Only a few places left - sign up today!> more

Displaying results 1 to 7 out of 117
<< First < Previous 1-7 8-14 15-21 22-28 29-35 36-42 43-49 Next > Last >>